Equities research analysts expect Addus Homecare Co. (NASDAQ:ADUS) to announce sales of $110.61 million for the current quarter, Zacks reports. Two analysts have provided estimates for Addus Homecare’s earnings, with the lowest sales estimate coming in at $109.40 million and the highest estimate coming in at $111.83 million. Addus Homecare reported sales of $101.61 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 8.9%. The firm is scheduled to announce its next earnings results on Monday, May 14th.
According to Zacks, analysts expect that Addus Homecare will report full year sales of $110.61 million for the current fiscal year, with estimates ranging from $452.70 million to $454.46 million. For the next financial year, analysts anticipate that the business will report sales of $479.57 million per share. Zacks’ sales averages are a mean average based on a survey of analysts that that provide coverage for Addus Homecare.
Several research analysts have recently weighed in on ADUS shares. BidaskClub upgraded Addus Homecare from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. Zacks Investment Research upgraded Addus Homecare from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 9th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Addus Homecare currently has an average rating of “Hold” and an average target price of $41.33.
In related news, insider James Zoccoli sold 725 shares of the company’s stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $35.90, for a total value of $26,027.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R Dirk Allison sold 911 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $34.04, for a total value of $31,010.44. Following the completion of the transaction, the chief executive officer now owns 42,986 shares in the company, valued at $1,463,243.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,226 shares of company stock worth $219,871. Insiders own 35.80% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. MetLife Investment Advisors LLC acquired a new position in Addus Homecare in the fourth quarter valued at approximately $146,000. First Trust Advisors LP acquired a new position in Addus Homecare in the third quarter valued at approximately $207,000. The Manufacturers Life Insurance Company lifted its holdings in Addus Homecare by 8.5% in the second quarter. The Manufacturers Life Insurance Company now owns 6,614 shares of the company’s stock valued at $246,000 after acquiring an additional 517 shares during the last quarter. Goldman Sachs Group Inc. acquired a new position in Addus Homecare in the fourth quarter valued at approximately $258,000. Finally, Los Angeles Capital Management & Equity Research Inc. lifted its holdings in Addus Homecare by 46.3% in the third quarter. Los Angeles Capital Management & Equity Research Inc. now owns 10,393 shares of the company’s stock valued at $367,000 after acquiring an additional 3,290 shares during the last quarter. Hedge funds and other institutional investors own 58.88% of the company’s stock.
Shares of Addus Homecare (NASDAQ:ADUS) traded down $0.05 during trading on Wednesday, hitting $37.10. The stock had a trading volume of 1,716 shares, compared to its average volume of 22,811. The firm has a market cap of $419.32, a PE ratio of 24.69, a P/E/G ratio of 1.59 and a beta of 0.13. Addus Homecare has a fifty-two week low of $29.90 and a fifty-two week high of $40.75. The company has a current ratio of 2.68, a quick ratio of 2.68 and a debt-to-equity ratio of 0.23.
ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Anticipate Addus Homecare Co. (ADUS) Will Post Quarterly Sales of $110.61 Million” was first reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another website, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/03/14/zacks-brokerages-anticipate-addus-homecare-co-adus-will-post-quarterly-sales-of-110-61-million.html.
Addus Homecare Company Profile
Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.